Skip to main content
Peptide compounds discussed on this site are for educational and research purposes. Always consult a qualified specialist before use.
Reference Selank 15mg FOR RESEARCH
Approved Evidence Stage
Cognitive Primary Domain
Intranasal administration Routes Studied
60+ PubMed Citations
Cognitive Peptide
Approved Therapeutic

Selank

Synthetic peptide studied in clinical and preclinical models for anxiolysis without sedation and preserved cognitive function

Last updated: March 1, 2026

Compound Data Sheet
Peer-reviewed References
Evidence Graded
Independent Editorial
Compound
Selank
Class
Cognitive peptide
Summary
Synthetic peptide studied in clinical and preclinical models for anxiolysis without sedation, preserved cognitive function, immune system modulation.
Mechanism
Hippocampal Gene Expression
Research Status
Approved
Routes Studied
Intranasal administration
Evidence Level
Clinically validated · Approved therapeutic
[ QUICK.ANSWERS ]

What Should You Know About Selank?

What is Selank?
Selank is a synthetic peptide studied in clinical and preclinical models for anxiolysis without sedation and preserved cognitive function.
Is Selank clinically proven?
Selank is an approved therapeutic with established clinical evidence.
What has Selank been studied for?
Selank has been studied in clinical and preclinical settings of anxiolysis without sedation, preserved cognitive function, immune system modulation and has received regulatory approval in at least one jurisdiction.
Is Selank approved?
Selank is an approved therapeutic in at least one jurisdiction. Regulatory status varies by country. Consult a local specialist for guidance.
[ COMPOUND.PROFILE ]

What Is Selank?

Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) is a synthetic heptapeptide developed at the Institute of Molecular Genetics of the Russian Academy of Sciences as an analogue of the endogenous immunomodulatory peptide tuftsin (Thr-Lys-Pro-Arg). By extending tuftsin's tetrapeptide sequence with a Pro-Gly-Pro tripeptide tail, a structural motif that enhances metabolic stability, researchers created a compound with significantly improved bioavailability and an expanded pharmacological profile that encompasses both anxiolytic and nootropic properties.

[ EVIDENCE.SUMMARY ]

Evidence Summary

Clinically validated · Approved therapeutic

Selank is an approved therapeutic with established clinical evidence and regulatory approval in at least one jurisdiction.

Evidence Breakdown

Domain Evidence Level
Anxiolysis Without Sedation Limited
Preserved Cognitive Function Limited
Immune System Modulation Limited
No Dependence or Tolerance Limited
Human clinical evidence Established
Safety data Established

Editorial Position

Selank is an approved therapeutic with established clinical evidence. As with any pharmaceutical compound, individual suitability should be discussed with a specialist.

Regulatory Status Snapshot

  • Approved as a therapeutic drug in at least one jurisdiction
  • Safety and efficacy established through regulatory review processes

Need help interpreting this evidence for your situation?

Talk to a Specialist
[ STUDIED.FOR ]

What Has Selank Been Studied For?

Research areas where Selank has been investigated in published studies

  • Anxiolysis Without Sedation Selank has been studied in clinical and preclinical studies of anxiolysis without sedation.
  • Preserved Cognitive Function Selank has been studied in clinical and preclinical studies of preserved cognitive function.
  • Immune System Modulation Selank has been studied in clinical and preclinical studies of immune system modulation.
  • No Dependence or Tolerance Selank has been studied in clinical and preclinical studies of no dependence or tolerance.
[ MECHANISM ]

How Does Selank Work?

These mechanisms have been established through clinical and preclinical research.

  1. 01 GABA-A Receptor Subunit Modulation
  2. 02 Serotonergic Metabolism Modulation
  3. 03 Dopaminergic Fine-Tuning
  4. 04 Immunomodulatory Signaling
NEXT STEP

Not sure if Selank is right for you?

A specialist can review the evidence, evaluate your medical context, and help you make an informed decision about Selank.

Speak with a Specialist
[ COMMUNITY.FEEDBACK ]

Community Reports (Anecdotal)

Experiences shared here are self-reported and do not represent clinical evidence.

Rate Selank

Your privacy is protected. Share anonymously if you prefer.
Your Rating
[ ADMINISTRATION ]

How Is Selank Administered?

Selank is available via Intranasal administration. Appropriate use and protocol should be determined by a qualified specialist.

[ REFERENCE.DATA ]

What Are the Specifications of Selank?

Format Nasal Spray Preparation
Amount 15mg total
Purity >99.6%
Purity Method HPLC (High-Performance Liquid Chromatography)
Sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro
Molecular Weight 751.90 g/mol
Storage Store at 2-8°C. Protect from light. Use within 30 days of opening.
Appearance Clear to slightly yellow solution
[ EXPLORE ]

What Conditions Has Selank Been Linked To?

Have Questions About Selank?

Selank's origin as a tuftsin analogue gives it immunomodulatory properties that traditional anxiolytics lack. Research shows it modulates interleukin and interferon gene expression, potentially rebalancing immune function disrupted by chronic stress.

Selank and Semax are complementary nootropic peptides developed at the same Russian research institute. Selank primarily provides anxiolytic (calming) effects through GABAergic modulation while preserving cognition. Semax primarily provides stimulating nootropic effects through BDNF upregulation and dopaminergic enhancement.

Published studies on Selank can be found on PubMed and other peer-reviewed databases. Our references section below lists key citations.

Ready to discuss Selank with a specialist?

Get evidence-based guidance tailored to your health goals and medical context.

Book a Consultation Free initial consultation. No obligation.
EDITORIAL REVIEW

Reviewed by the Peptide Science Thailand Editorial Team.

Last reviewed: March 1, 2026

Share Your Experience

Not Medical Advice

The information provided on this website, including compound profiles, mechanism of action explanations, research summaries, dosage information, and educational content, is for informational and educational purposes only. This information does not constitute medical advice, diagnosis, or treatment recommendations. No content on this website should be interpreted as a substitute for professional medical advice, diagnosis, or treatment.

Medical Supervision Essential

All peptide compounds discussed on this website should only be used under the supervision of a qualified specialist. A healthcare provider should evaluate individual health status, medical history, current medications, and specific health objectives before any peptide use. Self-administration of research peptides without medical supervision is strongly discouraged and may pose significant health risks.

Individual Variation

Individual responses to peptide compounds vary significantly based on genetics, age, body composition, existing health conditions, concurrent medications, and other biological factors. Dosage information provided on this website represents general research ranges and should not be used for self-dosing. A qualified specialist should determine the appropriate compound, dosage, administration route, cycle duration, and monitoring protocol based on individual health assessment.

Liability Limitation

Peptide Science Thailand assumes no liability for the misuse of information provided on this website. The content is provided for educational purposes only. Users are responsible for ensuring they work with qualified healthcare providers before using any peptide compounds discussed herein. Peptide Science Thailand is not responsible for adverse effects resulting from use without proper medical oversight.

Regulatory Status

Many peptides discussed here have not been evaluated or approved by the FDA for therapeutic use unless specifically noted (e.g., Tesamorelin, PT-141). The regulatory status of peptide compounds varies by jurisdiction. Some compounds discussed on this website are approved medications in other countries (e.g., Semax and Selank in Russia). This content is for informational and educational purposes only. Users are responsible for understanding and complying with all applicable laws and regulations in their jurisdiction.